Mark C. Hammer
Albany Medical College
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Mark C. Hammer.
American Heart Journal | 1982
Aldona L. Baltch; Charlene Schaffer; Mark C. Hammer; Nancy T. Sutphen; Raymond P. Smith; Joseph V. Conroy; Mehdi Shayegani
The rate, type, and magnitude of bacteremia were studied in 56 patients undergoing dental cleaning with and without penicillin prophylaxis. Sixty-one percent of patients without penicillin prophylaxis were bacteremic 5 minutes following the procedure. Although a significant decrease in detectable bacteremia occurred in patients receiving penicillin prophylaxis, the recovery of streptococci was not significantly different in the two groups. Using the present sample of patients as a basis for statistical inference, the true rate of bacteremia in such patients could be between 41% and 79% with 95% certainty. The magnitude of bacteremia was low and positive quantitative pour plates occurred at 5 minutes and only in patients without penicillin prophylaxis. Of the 71 total bacterial isolates, 53 (74.6%) were anaerobes and 18 (25.4%) were aerobes. This study indicates that parenteral penicillin prophylaxis for dental cleaning decreased detectable bacteremia rates significantly and could be recommended for patients with valvular heart disease who are known to be vulnerable to endocarditis.
Diabetes Research and Clinical Practice | 1987
Morteza Naghibi; Raymond P. Smith; Aldona L. Baltch; Sherman A. Gates; David H. Wu; Mark C. Hammer; Phyllis B. Michelsen
We studied the bactericidal activity (against P. aeruginosa) and chemotactic ability of polymorphonuclear leukocytes from 26 diabetic patients in three treatment groups (oral hypoglycemic, daily insulin, and continuous insulin infusion). Patients were studied before entry into intensified management protocols, and after intensified management in 11 of the 26 patients. Diabetic serum had a persistent inhibitory effect on both diabetic and normal white cells, but normal serum was unable to fully correct diabetic white cell killing to control values. After intensified management of diabetes, there was an improvement in bactericidal function of diabetic patient white cells, but not in the effect of diabetic serum. Diabetic serum, and to a lesser extent diabetic white blood cells, are defective mediators of killing of P. aeruginosa. Chemotaxis was normal in all patient groups. These findings confirm the earlier work of others showing that some patients with diabetes mellitus have a defect in host defense against infection with bacteria.
Journal of Trauma-injury Infection and Critical Care | 1986
Aldona L. Baltch; Mark C. Hammer; Raymond P. Smith; Monica B. Bishop; Nancy T. Sutphen; Mary A. Egy; Phyllis B. Michelsen
The effect of hydrocortisone, methylprednisolone, and dexamethasone on the phagocytic and bactericidal capabilities of normal human granulocytes (PMN) was studied under previously described optimal conditions for Pseudomonas aeruginosa, PA 1348A. At hydrocortisone and methylprednisolone concentrations of 1,000 micrograms/ml, delayed phagocytosis was clearly observed, whereas dexamethasone 400 micrograms/ml had no effect on phagocytosis. The bactericidal effect of PMN on PA 1348A was significantly reduced by all three corticosteroids at highest concentrations (p less than 0.05). However, the effect of methylprednisolone was greatest and that of dexamethasone was least evident, 25% and 10% reduction in PMN bactericidal activity, respectively. Following exposure to the highest concentrations of corticosteroids, TEM observations correlated well with the PMN functional assays. While the observations of PMN and bacteria in controls, hydrocortisone, and dexamethasone preparations were similar, evidence for incomplete phagocytosis, lack of vacuole coalescence, minimal disruption of bacterial cell walls, and dividing bacteria in phagosomes were evident in methylprednisolone preparations. These PMN functional and TEM observations suggest that of the three corticosteroids studied, methylprednisolone appears most deleterious to the PMN phagocytic and bactericidal activity.
The American Journal of the Medical Sciences | 1981
Raymond P. Smith; George P. Schmid; Aldona L. Baltch; Nancy T. Sutphen; Mark C. Hammer
Concentration of cefaclor, a new oral cephalosporin, was measured in prostatic tissue of ten patients undergoing suprapubic prostatectomy. The average prostatic tissue concentrations were 0.51 — 0.22 microgram and 0.74 — 0.67 microgram per gram of tissue following the oral administration of 250-milligram and 500-milligram doses, respectively. The prostate/plasma ratios of cefaclor were approximately 0.7 indicating no evidence of accumulation of the drug in prostatic tissue. Levels of cefaclor achieved in human prostatic disease are equal to or less than the minimum inhibitory concentration of most strains of known facultative bacterial pathogens associated with prostatitis.
Cryobiology | 1986
Mark C. Hammer; Aldona L. Baltch; Joseph V. Conroy; Raymond P. Smith
This study was undertaken to determine the effects of different incubation conditions on human granulocyte (PMN) bactericidal, phagocytic, and chemotactic functions. Specifically, (1) how long may a patients blood be held before assay and maintain original PMN function, and (2) how long may isolated PMNs be incubated for the purpose of exposure to various agents and still maintain original function? PMNs isolated following storage of whole heparinized blood at 4 degrees C for 24 and 48 hr phagocytized as well as fresh cells and their bactericidal activity was 96 and 85% of control values after 24 and 48 hr, respectively. Chemotaxis decreased to 62% of control after 24 hr. The bactericidal capacity of isolated PMNs stored at 4 degrees C for 24, 48, and 72 hr decreased to 85, 81, and 78% of controls, respectively. Phagocytosis after 24 hr storage was equal to controls. Chemotaxis was decreased to 59 and 34% of controls after 24 and 48 hr, respectively. Isolated PMNs incubated at 37 degrees C demonstrated impairment in phagocytic capacity after only 4 hr.
JAMA Internal Medicine | 1988
Aldona L. Baltch; Howard L. Pressman; Charlene Schaffer; Raymond P. Smith; Mark C. Hammer; Mehdi Shayegani; Phyllis B. Michelsen
Journal of Antimicrobial Chemotherapy | 1989
David M. Liebers; Aldona L. Baltch; Raymond P. Smith; Mark C. Hammer; Joseph V. Conroy
The Journal of Infectious Diseases | 1983
Joseph V. Conroy; Aldona L. Baltch; Raymond P. Smith; Mark C. Hammer; Paul E. Griffin
Canadian Journal of Microbiology | 1987
Aldona L. Baltch; Tom G. Obrig; Raymond P. Smith; Mark C. Hammer; Joseph V. Conroy; Frieder Lutz
Journal of Antimicrobial Chemotherapy | 1988
D. M. Liebers; Aldona L. Baltch; Raymond P. Smith; Mark C. Hammer; Joseph V. Conroy; M. Shayegani